Research graph
References from Blood nutritional and immune indices in lung cancer: a narrative review of prognostic significance, treatment response, and clinical applications. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer treatment and survivorship statistics, 2019
2019 · External reference
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · External reference
Epidemiology of lung cancer
2019 · External reference
Prognostic factors and prognostic staging system for small cell lung cancer
10.1093/jjco/27.3.158 · 1997 · External reference
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
10.3904/kjim.2015.062 · 2016 · External reference
Association between an inflammatory-nutritional index and nutritional status in cancer patients
2013 · External reference
Cancer-related inflammation
10.1038/nature07205 · 2008 · External reference
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
10.1093/ajcn/83.6.1345 · 2006 · External reference
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: a comprehensive analysis of systemic inflammatory markers
10.1016/j.suronc.2018.01.002 · 2018 · External reference
The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI
10.2147/ijgm.s174605 · 2018 · External reference
Prognostic value of neutrophil-to-lymphocyte ratio in patients with lung adenocarcinoma treated with radical dissection
2018 · External reference
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
10.1007/s00262-020-02585-w · 2020 · External reference
Emerging blood-based biomarkers for predicting response to checkpoint immunotherapy in non-small-cell lung cancer
10.3389/fimmu.2020.603157 · 2020 · External reference
Identification of biomarkers for non-small-cell lung cancer patients treated with an immune checkpoint inhibitor
10.21873/anticanres.14379 · 2020 · External reference
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
10.1016/j.lungcan.2020.08.015 · 2020 · External reference
Peripheral blood markers identify risk of immune-related toxicity in advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
10.1634/theoncologist.2018-0563 · 2019 · External reference
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments
10.21037/tlcr-21-710 · 2021 · External reference
Prognostic value of pre-treatment prognostic nutritional index in esophageal cancer: a systematic review and meta-analysis
10.3389/fonc.2020.00797 · 2020 · External reference
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
10.1007/s00432-014-1714-3 · 2014 · External reference
Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis
10.1177/1724600818799876 · 2018 · External reference
Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis
10.1016/j.cca.2018.08.030 · 2018 · External reference
The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer
2021 · External reference
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European school of oncology task force
10.1093/annonc/mdu085 · 2014 · External reference
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
10.1016/j.jhep.2012.08.017 · 2013 · External reference
Neutrophil-lymphocyte ratio (NLR) predicted prognosis for advanced non-small-cell lung cancer (NSCLC) patients who received immune checkpoint blockade (ICB)
10.2147/ott.s199176 · 2019 · External reference
Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: results from a large cohort
10.1111/1759-7714.12454 · 2017 · External reference
Prognostic significance of pre-operative monocyte-to-lymphocyte ratio in lung cancer patients undergoing radical surgery
10.1093/labmed/lmx069 · 2018 · External reference
An elevated peripheral blood monocyte-to-lymphocyte ratio predicts poor prognosis in patients with primary pulmonary lymphoepithelioma-like carcinoma
2015 · External reference
The relation between hemogram parameters and survival in extensive-stage small cell lung cancer
10.1159/000501595 · 2019 · External reference
Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis
10.1016/j.cca.2018.04.012 · 2018 · External reference
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
10.1186/s12885-019-5490-y · 2019 · External reference
Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
10.1042/bsr20200352 · 2020 · External reference
Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases
10.2217/fon-2020-0423 · 2020 · External reference
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
10.1186/1471-2407-13-158 · 2013 · External reference
Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer
10.1186/s12967-017-1326-1 · 2017 · External reference
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
2017 · External reference
Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
10.1111/crj.12925 · 2018 · External reference
Comparison of the prognostic value of systemic inflammation response markers in small cell lung cancer patients
10.7150/jca.29319 · 2019 · External reference
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
10.1186/s12957-015-0710-7 · 2015 · External reference
Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer
10.1093/jjco/hyy014 · 2018 · External reference
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer
10.1016/j.lungcan.2016.05.010 · 2016 · External reference
The prognostic value of serum albumin-globulin ratio in early-stage non-small cell lung cancer: a retrospective study
10.2147/cmar.s191288 · 2019 · External reference
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer
10.1007/s10147-019-01539-2 · 2020 · External reference
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients
10.1016/j.lungcan.2017.11.002 · 2017 · External reference
Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer
10.1111/ajco.13055 · 2018 · External reference
Neutrophil-lymphocyte ratio is a prognostic marker in patients with locally advanced (stage IIIA and IIIB) non-small cell lung cancer treated with combined modality therapy
10.1634/theoncologist.2016-0443 · 2017 · External reference
Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: a retrospective study
10.1111/1759-7714.13085 · 2019 · External reference
Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study
10.1038/s41598-019-44653-x · 2019 · External reference
Tumor associated macrophages and neutrophils in tumor progression
10.1002/jcp.24260 · 2013 · External reference
Neutrophil-to-Lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with Nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective multicenter study
10.1007/s12325-020-01229-w · 2020 · External reference
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers
10.1371/journal.pone.0219060 · 2019 · External reference
Inflammation and cancer: back to Virchow?
10.1016/s0140-6736(00)04046-0 · 2001 · External reference
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma
10.1016/j.lungcan.2015.07.014 · 2015 · External reference
Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and meta-analysis
10.1159/000487734 · 2018 · External reference
Predictive value of preoperative albumin-to-fibrinogen ratio for postoperative survival of esophageal squamous cell carcinoma after radical esophagectomy
2019 · External reference
The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
2013 · External reference
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
10.1182/blood.v96.10.3302 · 2000 · External reference
Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer
2013 · External reference
Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals
10.1002/cam4.1428 · 2018 · External reference
Prognostic value of albumin fibrinogen ratio and platelet lymphocyte ratio in patients with non-small cell lung cancer
2020 · External reference
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
10.1158/1078-0432.ccr-14-0442 · 2014 · External reference
Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer
10.1620/tjem.236.297 · 2015 · External reference
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma
10.1002/jcp.27052 · 2019 · External reference
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
10.2147/cmar.s197623 · 2019 · External reference
Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC
10.1007/s11605-019-04492-7 · 2021 · External reference
Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis
10.7150/jca.25691 · 2018 · External reference
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
10.1016/j.suronc.2013.12.001 · 2014 · External reference
Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer
10.18632/oncotarget.14921 · 2017 · External reference
Elevated mean platelet volume predicts poor prognosis in colorectal cancer
2017 · External reference
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
10.18632/oncotarget.8309 · 2016 · External reference
Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
10.1245/s10434-016-5634-0 · 2017 · External reference
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer
10.3892/mco.2015.557 · 2015 · External reference
Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer
10.1016/j.tranon.2016.10.006 · 2017 · External reference
Prognostic impact of neutrophil lymphocyte ratio and platelet lymphocyte ratio on patients with small cell lung cancer
2018 · External reference
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
10.1038/sj.bjc.6600466 · 2002 · External reference
Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis
10.1186/s12957-019-1725-2 · 2019 · External reference
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer
10.1002/cam4.1234 · 2018 · External reference
Exploring the value of advanced lung cancer inflammation index (ALI) in prognosis assessment of lung cancer
2019 · External reference
Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
10.1111/crj.12768 · 2018 · External reference
The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study
10.7717/peerj.10100 · 2020 · External reference
Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
10.1007/s00405-019-05381-0 · 2019 · External reference
Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: a propensity score matching analysis
10.1016/j.clnu.2020.07.018 · 2021 · External reference
Low advanced lung cancer inflammation index predicts poor prognosis in locally advanced nasopharyngeal carcinoma patients treated with definitive concurrent chemoradiotherapy
10.1155/2020/3127275 · 2020 · External reference
Prognostic nutritional index in gastrointestinal surgery
10.1016/0002-9610(80)90246-9 · 1980 · External reference
[prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]
1984 · External reference
Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study
10.1093/icvts/ivx337 · 2018 · External reference
Prognostic value of pretreatment albumin to globulin ratio in lung cancer: a meta-analysis
10.1080/01635581.2020.1737155 · 2021 · External reference
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
10.2147/ott.s109736 · 2016 · External reference
The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
10.1038/s41598-020-68975-3 · 2020 · External reference
Preoperative albumin level is superior to albumin-globulin ratio as A predicting indicator in gastric cancer patients who underwent curative resection
10.2147/cmar.s230741 · 2019 · External reference
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome
10.7861/clinmedicine.9-1-30 · 2009 · External reference
The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma
10.1245/s10434-014-4048-0 · 2015 · External reference
Prognostic significance of the preoperative ratio of C-Reactive protein to albumin in patients with colorectal cancer
2016 · External reference
Preoperative C-Reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer
10.1016/j.tranon.2015.06.006 · 2015 · External reference
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
10.1007/s13277-016-5122-y · 2016 · External reference
The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection
10.1007/s00268-016-3491-4 · 2016 · External reference
Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
10.4251/wjgo.v8.i7.555 · 2016 · External reference
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
10.1186/s12885-015-1379-6 · 2015 · External reference
A novel inflammation-based prognostic score, the C-Reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma
10.1371/journal.pone.0138657 · 2015 · External reference
Exploration and validation of C-Reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma
10.7150/jca.15401 · 2016 · External reference
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
10.18632/oncotarget.13053 · 2017 · External reference
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer
10.1002/cam4.1234 · ExternalCitation · doi-reference
Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals
10.1002/cam4.1428 · ExternalCitation · doi-reference
Tumor associated macrophages and neutrophils in tumor progression
10.1002/jcp.24260 · ExternalCitation · doi-reference
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma
10.1002/jcp.27052 · ExternalCitation · doi-reference
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
10.1007/s00262-020-02585-w · ExternalCitation · doi-reference
The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection
10.1007/s00268-016-3491-4 · ExternalCitation · doi-reference
Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
10.1007/s00405-019-05381-0 · ExternalCitation · doi-reference
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
10.1007/s00432-014-1714-3 · ExternalCitation · doi-reference
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer
10.1007/s10147-019-01539-2 · ExternalCitation · doi-reference
Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC
10.1007/s11605-019-04492-7 · ExternalCitation · doi-reference
Neutrophil-to-Lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with Nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective multicenter study
10.1007/s12325-020-01229-w · ExternalCitation · doi-reference
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
10.1007/s13277-016-5122-y · ExternalCitation · doi-reference
Prognostic nutritional index in gastrointestinal surgery
10.1016/0002-9610(80)90246-9 · ExternalCitation · doi-reference
Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis
10.1016/j.cca.2018.04.012 · ExternalCitation · doi-reference
Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis
10.1016/j.cca.2018.08.030 · ExternalCitation · doi-reference
Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: a propensity score matching analysis
10.1016/j.clnu.2020.07.018 · ExternalCitation · doi-reference
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
10.1016/j.jhep.2012.08.017 · ExternalCitation · doi-reference
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma
10.1016/j.lungcan.2015.07.014 · ExternalCitation · doi-reference
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer
10.1016/j.lungcan.2016.05.010 · ExternalCitation · doi-reference
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients
10.1016/j.lungcan.2017.11.002 · ExternalCitation · doi-reference
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
10.1016/j.lungcan.2020.08.015 · ExternalCitation · doi-reference
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
10.1016/j.suronc.2013.12.001 · ExternalCitation · doi-reference
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: a comprehensive analysis of systemic inflammatory markers
10.1016/j.suronc.2018.01.002 · ExternalCitation · doi-reference
Preoperative C-Reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer
10.1016/j.tranon.2015.06.006 · ExternalCitation · doi-reference
Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer
10.1016/j.tranon.2016.10.006 · ExternalCitation · doi-reference
Inflammation and cancer: back to Virchow?
10.1016/s0140-6736(00)04046-0 · ExternalCitation · doi-reference
Cancer-related inflammation
10.1038/nature07205 · ExternalCitation · doi-reference
Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study
10.1038/s41598-019-44653-x · ExternalCitation · doi-reference
The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
10.1038/s41598-020-68975-3 · ExternalCitation · doi-reference
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
10.1038/sj.bjc.6600466 · ExternalCitation · doi-reference
Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
10.1042/bsr20200352 · ExternalCitation · doi-reference
Prognostic value of pretreatment albumin to globulin ratio in lung cancer: a meta-analysis
10.1080/01635581.2020.1737155 · ExternalCitation · doi-reference
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
10.1093/ajcn/83.6.1345 · ExternalCitation · doi-reference
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European school of oncology task force
10.1093/annonc/mdu085 · ExternalCitation · doi-reference
Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study
10.1093/icvts/ivx337 · ExternalCitation · doi-reference
Prognostic factors and prognostic staging system for small cell lung cancer
10.1093/jjco/27.3.158 · ExternalCitation · doi-reference
Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer
10.1093/jjco/hyy014 · ExternalCitation · doi-reference
Prognostic significance of pre-operative monocyte-to-lymphocyte ratio in lung cancer patients undergoing radical surgery
10.1093/labmed/lmx069 · ExternalCitation · doi-reference
Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: results from a large cohort
10.1111/1759-7714.12454 · ExternalCitation · doi-reference
Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: a retrospective study
10.1111/1759-7714.13085 · ExternalCitation · doi-reference
Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer
10.1111/ajco.13055 · ExternalCitation · doi-reference
Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
10.1111/crj.12768 · ExternalCitation · doi-reference
Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
10.1111/crj.12925 · ExternalCitation · doi-reference
Low advanced lung cancer inflammation index predicts poor prognosis in locally advanced nasopharyngeal carcinoma patients treated with definitive concurrent chemoradiotherapy
10.1155/2020/3127275 · ExternalCitation · doi-reference
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
10.1158/1078-0432.ccr-14-0442 · ExternalCitation · doi-reference
Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and meta-analysis
10.1159/000487734 · ExternalCitation · doi-reference
The relation between hemogram parameters and survival in extensive-stage small cell lung cancer
10.1159/000501595 · ExternalCitation · doi-reference
Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: a systematic review and meta-analysis
10.1177/1724600818799876 · ExternalCitation · doi-reference
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
10.1182/blood.v96.10.3302 · ExternalCitation · doi-reference
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
10.1186/1471-2407-13-158 · ExternalCitation · doi-reference
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
10.1186/s12885-015-1379-6 · ExternalCitation · doi-reference
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
10.1186/s12885-019-5490-y · ExternalCitation · doi-reference
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
10.1186/s12957-015-0710-7 · ExternalCitation · doi-reference
Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis
10.1186/s12957-019-1725-2 · ExternalCitation · doi-reference
Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer
10.1186/s12967-017-1326-1 · ExternalCitation · doi-reference
The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma
10.1245/s10434-014-4048-0 · ExternalCitation · doi-reference
Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
10.1245/s10434-016-5634-0 · ExternalCitation · doi-reference
A novel inflammation-based prognostic score, the C-Reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma
10.1371/journal.pone.0138657 · ExternalCitation · doi-reference
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers
10.1371/journal.pone.0219060 · ExternalCitation · doi-reference
Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer
10.1620/tjem.236.297 · ExternalCitation · doi-reference
Neutrophil-lymphocyte ratio is a prognostic marker in patients with locally advanced (stage IIIA and IIIB) non-small cell lung cancer treated with combined modality therapy
10.1634/theoncologist.2016-0443 · ExternalCitation · doi-reference
Peripheral blood markers identify risk of immune-related toxicity in advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
10.1634/theoncologist.2018-0563 · ExternalCitation · doi-reference
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
10.18632/oncotarget.13053 · ExternalCitation · doi-reference
Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer
10.18632/oncotarget.14921 · ExternalCitation · doi-reference
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
10.18632/oncotarget.8309 · ExternalCitation · doi-reference
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments
10.21037/tlcr-21-710 · ExternalCitation · doi-reference
The prognostic value of serum albumin-globulin ratio in early-stage non-small cell lung cancer: a retrospective study
10.2147/cmar.s191288 · ExternalCitation · doi-reference
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
10.2147/cmar.s197623 · ExternalCitation · doi-reference
Preoperative albumin level is superior to albumin-globulin ratio as A predicting indicator in gastric cancer patients who underwent curative resection
10.2147/cmar.s230741 · ExternalCitation · doi-reference
The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI
10.2147/ijgm.s174605 · ExternalCitation · doi-reference
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
10.2147/ott.s109736 · ExternalCitation · doi-reference
Neutrophil-lymphocyte ratio (NLR) predicted prognosis for advanced non-small-cell lung cancer (NSCLC) patients who received immune checkpoint blockade (ICB)
10.2147/ott.s199176 · ExternalCitation · doi-reference
Identification of biomarkers for non-small-cell lung cancer patients treated with an immune checkpoint inhibitor
10.21873/anticanres.14379 · ExternalCitation · doi-reference
Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases
10.2217/fon-2020-0423 · ExternalCitation · doi-reference
Emerging blood-based biomarkers for predicting response to checkpoint immunotherapy in non-small-cell lung cancer
10.3389/fimmu.2020.603157 · ExternalCitation · doi-reference
Prognostic value of pre-treatment prognostic nutritional index in esophageal cancer: a systematic review and meta-analysis
10.3389/fonc.2020.00797 · ExternalCitation · doi-reference
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer
10.3892/mco.2015.557 · ExternalCitation · doi-reference
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
10.3904/kjim.2015.062 · ExternalCitation · doi-reference
Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
10.4251/wjgo.v8.i7.555 · ExternalCitation · doi-reference
Exploration and validation of C-Reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma
10.7150/jca.15401 · ExternalCitation · doi-reference
Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis
10.7150/jca.25691 · ExternalCitation · doi-reference
Comparison of the prognostic value of systemic inflammation response markers in small cell lung cancer patients
10.7150/jca.29319 · ExternalCitation · doi-reference
The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study
10.7717/peerj.10100 · ExternalCitation · doi-reference
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome
10.7861/clinmedicine.9-1-30 · ExternalCitation · doi-reference
